BISPECIFIC ANTIBODIES
    6.
    发明申请
    BISPECIFIC ANTIBODIES 审中-公开
    双重抗体

    公开(公告)号:US20080305105A1

    公开(公告)日:2008-12-11

    申请号:US11754792

    申请日:2007-05-29

    摘要: The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.

    摘要翻译: 本发明公开了在单个多肽链上包含两个抗体可变结构域的双特异性抗体,其中双特异性抗体的第一部分能够通过特异性结合人免疫效应细胞上的效应物抗原募集人免疫效应细胞的活性 ,第一部分由一个抗体可变结构域组成,第二部分特异性结合除效应物抗原之外的靶抗原的双特异性抗体,除人免疫效应细胞以外的靶细胞上的靶抗原,第二部分包含 一个抗体可变结构域。

    Bispecific antibodies
    7.
    发明授权
    Bispecific antibodies 有权
    双特异性抗体

    公开(公告)号:US07235641B2

    公开(公告)日:2007-06-26

    申请号:US10743697

    申请日:2003-12-22

    IPC分类号: C07K16/18 C07K16/28 G01N33/53

    摘要: The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.

    摘要翻译: 本发明公开了在单个多肽链上包含两个抗体可变结构域的双特异性抗体,其中双特异性抗体的第一部分能够通过特异性结合人免疫效应细胞上的效应物抗原募集人免疫效应细胞的活性 ,第一部分由一个抗体可变结构域组成,第二部分特异性结合除效应物抗原之外的靶抗原的双特异性抗体,除人免疫效应细胞以外的靶细胞上的靶抗原,第二部分包含 一个抗体可变结构域。